NCT07247474 Triple EIT (Electrical Impedance Tomography)
| NCT ID | NCT07247474 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Neonates and Preterm Infants |
| Study Type | OBSERVATIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2028-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 140 participants in total. It began in 2026-01-30 with a primary completion date of 2028-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study plans to learn more about ways to look at participant's lungs using new machines called Electrical Impedance Tomography (EIT). The EIT does not use harmful radiation like CT or x-ray. It is read through electrodes like using EKG reading heartbeats. The investigators want to compare the results of patients who have chronic respiratory disease to patients without chronic respiratory disease to learn more about lung structure and composition.
Eligibility Criteria
Inclusion Criteria: * 2 weeks to 25 years of age * evidence of cardiopulmonary disease including, but not limited to: 1. Post-prematurity respiratory disease 2. Congenital diaphragmatic hernia 3. Pulmonary Hypertension 4. Congenital heart disease 5. Respiratory failure 6. Neuromuscular Disease 7. Developmental or congenital lung disease OR matched healthy controls (born at term gestation (\>36 weeks gestational age) with no cardiopulmonary disease) Exclusion Criteria: * \<2 weeks of age * Anything that interferes with lead placement on the chest wall (such as, dermatologic conditions, multiple chest tubes, anatomic abnormality, or large dressings that cannot be moved) * No informed consent * Pregnant or lactating * Pacemaker or other metal intrathoracic surgical implant (causes noise in the data)
Contact & Investigator
Katelyn Enzer, MD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT07247474 clinical trial?
This trial is open to participants of all sexes, aged 2 Weeks or older, up to 25 Years, studying Neonates and Preterm Infants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07247474 currently recruiting?
Yes, NCT07247474 is actively recruiting participants. Contact the research team at allison.keck@childrenscolorado.org for enrollment information.
Where is the NCT07247474 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT07247474 clinical trial?
NCT07247474 is sponsored by University of Colorado, Denver. The principal investigator is Katelyn Enzer, MD at University of Colorado, Denver. The trial plans to enroll 140 participants.